Esperion Therapeutics, Inc. (LON:0IIM)
0.7862
-0.1139 (-12.65%)
At close: May 9, 2025
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of 118.97 million as of May 9, 2025. Its market cap has decreased by -63.34% in one year.
Market Cap
118.97M
Enterprise Value
479.48M
Revenue
200.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.79
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has decreased from 137.93M to 118.97M, a decrease of -13.74%. That is a compound annual growth rate of -1.24%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 158.79B |
GSK plc | 55.98B |
Haleon | 36.67B |
Smith & Nephew | 9.35B |
ConvaTec Group | 5.26B |
Hikma Pharmaceuticals | 4.42B |
HUTCHMED (China) | 1.95B |
Genus | 1.39B |